Dr. Golbe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
125 Paterson Street
CAB# 6200
New Brunswick, NJ 08901Phone+1 732-235-7733Fax+1 732-235-7041
Education & Training
- NYU Grossman School of MedicineResidency, Neurology, 1980 - 1983
- Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1978 - 1980
- New York University School of MedicineClass of 1978
Certifications & Licensure
- NJ State Medical License 1983 - 2023
- PA State Medical License 1979 - 1981
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2014
- America's Top Doctors Castle Connolly, 2003-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- Join now to see all
Clinical Trials
- Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy Start of enrollment: 2015 Oct 02
Publications & Presentations
PubMed
- Author Correction: Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes.Kurt Farrell, Jack Humphrey, Timothy Chang, Yi Zhao, Yuk Yee Leung
Nature Communications. 2024-11-13 - Combined Assessment of Function and Survival to Demonstrate the Effect of Treatment on Progressive Supranuclear Palsy.Massimiliano Germani, Irene Rebollo Mesa, Tim J Buchanan, Steven De Bruyn, Teresa Gasalla
Movement Disorders. 2024-10-29 - Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes.Kurt Farrell, Jack Humphrey, Timothy Chang, Yi Zhao, Yuk Yee Leung
Nature Communications. 2024-09-09
Press Mentions
- Supports the FTD Disorders Registry with $100,000 GrantNovember 12th, 2019
- Pinteon Therapeutics Launches Phase 1 Trial of Novel Tau Antibody That Targets a Potent Driver of Neurodegenerative DiseaseOctober 31st, 2019
- CurePSP Awards Seven New Research GrantsJuly 29th, 2019
Grant Support
- Glutathione S-Transferase Polymorphisms In Park1 Parkin*National Institute Of Neurological Disorders And Stroke2002–2003
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: